Marrone Bio Innovations Launches TerraConnect™ New Biological Seed and Soil Platform
DAVIS, Calif., Dec. 06, 2018 (GLOBE NEWSWIRE) --
Marrone Bio Innovations, Inc. (MBII) (MBI),
launches TerraConnect, a new global biological soil applied and
seed treatment platform delivering growers high performance
products as well as a broad range of valuable tools to improve and
protect crops. TerraConnect is designed to address the need for
more sustainable food production systems, increasing regulatory
restrictions and the wellbeing of workers, consumers and beneficial
insects.
With estimates that the world’s population will increase from 7 to 10 billion by 2050, farmers need effective and environmentally sustainable solutions that are proven to work. Even with today’s technologies, over 40% of crop production is lost to fungal diseases, nematode and insect infestations. Our proprietary biologicals, microbes, and plant extracts offer broad spectrum control, which can be applied alone or combined with other soil or seed protection products as part of integrated management program; answering the call for high performing sustainable life science solutions.
At AgriThority’s 2018 “Exceed the Seed†symposium, Kevin Hammill, Chief Commercial Officer recently noted, “TerraConnect is a new global platform containing a suite of our soil applied and seed treatment products that help deliver solutions for customers who want strong and consistent performance to tackle the toughest pests and environmental stresses. TerraConnect is a tailored solution that benefits customers and consumers by uniting the power of biology with the performance of chemistry to protect & grow plants and our team is dedicated to working with key strategic partners to spread the benefits of this portfolio throughout the world.â€
Since its inception in 2006, MBI has long been known as the pioneering force of bio-based pest management. The company is well positioned to help customers seeking customized solutions in the soil applied and seed protection space. High performing biological solutions offer a new category of differentiated product combinations that directly support the evolving needs of farming. According to MarketsandMarkets February 2018 Top Market Report, the seed treatment market is projected to grow at a CAGR of 10.82% from USD $6.76 Billion in 2017, to reach USD $11.31 Billion by 2022. This is due to the increasing demand for integrated pest management practices to minimize pesticide usage, seed treatment products have been gaining preference for their beneficial characteristics such as the ability to combat early-season diseases and pests and their positive effect on crop yield.
About Marrone Bio
Innovations
Marrone Bio Innovations, Inc. (MBII)
strives to lead the movement to more sustainable world through the
discovery, development and sale of innovative biological products
for crop protection, plant health and waterway systems treatment.
MBI has screened over 18,000 microorganisms and 350 plant extracts,
leveraging its in-depth knowledge of plant and soil microbiomes
enhanced by advanced molecular technologies to rapidly develop
seven effective and environmentally responsible pest management
products to help customers operate more sustainably while uniquely
improving plant health and increasing crop yields. Supported by a
robust portfolio of over 400 issued and pending patents around its
superior natural product chemistry, MBI’s currently available
commercial products are Regalia®, Grandevo®, Venerate®, Majestene®,
Haven® Stargus®, Amplitude™, Zelto® and Zequanox®. TerraConnect™ is
MBI’s new seed treatment & soil applied
platform.
Marrone Bio Innovations is dedicated to
pioneering smart biopesticide and plant health solutions that
support a better tomorrow for farmers, turf managers and consumers
around the globe. Learn more about Marrone Bio Innovations
at:
marronebio.com
Follow us on Social Media:
twitter.com/marronebio
linkedin.com/company/marrone-bio/
instagram.com/marronebio/
Marrone Bio Innovations Forward Looking
Statements
This press release contains forward-looking statements that involve
substantial risks and uncertainties. All statements, other than
statements of historical facts, included in this press release
regarding strategy, future operations and plans, including
assumptions underlying such statements, are forward-looking
statements, and should not be relied upon as representing MBI’s
views as of any subsequent date. Examples of such statements
include the potential of the TerraConnect platform to drive sales,
provide market projections, and realize the potential benefits of
our products. Such forward-looking statements are based on
information available to the Company as of the date of this release
and involve a number of risks and uncertainties, some beyond the
Company’s control, that could cause actual results to differ
materially from those anticipated by these forward-looking
statements, including weather, regulatory and other factors
affecting demand for the MBI’s products, any difficulty in
marketing MBI’s products in its target markets, competition in the
market for pest management products, lack of understanding of
bio-based pest management products by customers and growers.
Additional information that could lead to material changes in MBI’s
performance is contained in its filings with the SEC. MBI is under
no obligation to, and expressly disclaims any responsibility to,
update or alter forward-looking statements contained in this
release, whether as a result of current information, future events
or otherwise.
Ag Trade Commercial
Inquires:
Alicia Gillman
Director, Communications
Marrone Bio Innovations
O: (480) 889-4219
E-Mail: [email protected]
MBI Investor Relations:
Greg Falesnik
Managing Director
MZ Group – MZ North America
Main: 949-385-6449
[email protected]
www.mzgroup.us
